Thromb Haemost 1963; 10(02): 309-316
DOI: 10.1055/s-0038-1654786
Originalarbeiten — Original Article — Travaux Originaux
Schattauer GmbH

Method for Determining ε-Aminocaproic Acid (EACA) in Blood Plasma, Based on the Antifibrinolytic Properties of this Compound

Nina Wolosowicz
1   Department of Physiological Chemistry (Head: Doz. S. Niewiarowski, M.D.), Bialystok, Poland
,
Stefan Niewiarowski
1   Department of Physiological Chemistry (Head: Doz. S. Niewiarowski, M.D.), Bialystok, Poland
,
Kazimierz Czerepko
1   Department of Physiological Chemistry (Head: Doz. S. Niewiarowski, M.D.), Bialystok, Poland
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Preview

Summary

A method was elaborated for determining e-aminocaproic acid (EACA) in blood plasma, based upon this compound’s antifibrinolytic activity.

Oxalated plasma was deproteinized in a boiling water-bath using trichloracetic acid. The latter was removed from plasma filtrate by means of ether extraction and the effect of the deproteinized extract on clot fibrinolysis time under standard conditions was tested. There was found a linear correlation of the logarithm of clot lysis time with EACA concentration.

The method appears to be fast and reliable, making possible serial determinations of the EACA level in blood plasma, the error being within the limits of 3 percent. It is suitable for the EACA level in plasma exceeding 2 mgVo.

The method is most specific. Various amino acids appearing naturally (except cysteine) do not interfere with determinations.

The EACA metabolism in vivo may be successfully studied using the above method.